Updated NICE guideline NG50 – ‘Cirrhosis in over 16s: assessment and management’
Updated recommendations on safe prescribing and use of carvedilol and propranolol in people with cirrhosis
This new update to NICE guideline NG50 includes new or updated recommendations on safe prescribing and use of carvedilol and propranolol in people with cirrhosis, detecting and preventing bleeding from medium or large varices, preventing spontaneous bacterial peritonitis, and primary prevention of decompensation.
The core guideline was originally released in 2016 and includes recommendations on diagnosing cirrhosis, as well as monitoring and managing complications, including hepatocellular carcinoma, decompensation, and spontaneous bacterial peritonitis.
Full details of this NICE guideline, including further information on the update can be found here: https://www.nice.org.uk/guidance/ng50